Canada markets close in 1 hour 19 minutes
  • S&P/TSX

    20,199.02
    -1.63 (-0.01%)
     
  • S&P 500

    4,249.86
    +3.42 (+0.08%)
     
  • DOW

    33,924.93
    -20.65 (-0.06%)
     
  • CAD/USD

    0.8130
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    73.08
    +0.23 (+0.32%)
     
  • BTC-CAD

    41,198.52
    +113.04 (+0.28%)
     
  • CMC Crypto 200

    804.03
    -6.16 (-0.76%)
     
  • GOLD FUTURES

    1,780.90
    +3.50 (+0.20%)
     
  • RUSSELL 2000

    2,310.40
    +14.45 (+0.63%)
     
  • 10-Yr Bond

    1.4870
    +0.0150 (+1.02%)
     
  • NASDAQ

    14,290.01
    +36.74 (+0.26%)
     
  • VOLATILITY

    16.29
    -0.37 (-2.22%)
     
  • FTSE

    7,074.06
    -15.95 (-0.22%)
     
  • NIKKEI 225

    28,874.89
    -9.24 (-0.03%)
     
  • CAD/EUR

    0.6810
    +0.0006 (+0.09%)
     

The global infection control market is projected to reach USD 52.7 billion by 2026 from USD 44.7 billion in 2021, at a CAGR of 3.4%

·6 min read

during the forecast period. Growth in the infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections; the increasing number of surgical procedures; the growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers.

New York, May 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Infection Control Market by Product, End User, COVID-19 Impact - Global Forecast to 2026" - https://www.reportlinker.com/p04230312/?utm_source=GNW
Currently, with the surge in cases of COVID-19, there is an increasing focus on personal hygiene and increasing production of medical nonwovens and single-use products, such as face masks and gloves. This, in turn, is expected to propel market growth in the next two years.
On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing, limited reimbursement in developing countries, and end-user non-compliance with sterilization standards, may hamper the growth of the market.

Based on product & service, the protective barriers segment holds the largest market share during the forecast period.
Based on products & services, the market is further classified into cleaning & disinfection products, sterilization products & services, endoscope reprocessing products, protective barriers, and other infection control products.The protective barriers market accounted for the largest share of the infection control market in 2020.

The large share of the protective barriers market can be attributed to the increasing adoption of medical nonwovens, such as face masks and surgical drapes & gowns, due to the current rise in COVID-19 cases.

Based on type, the sterilization equipment segment is expected to register the highest CAGR during the forecast period.
Based on type, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables & accessories.In 2020, the sterilization equipment segment accounted for the largest share and is also expected to grow at the highest CAGR during the forecast period.

This can be attributed to the growing emphasis on infection control measures and the increasing demand for sterilization technologies, such as radiation sterilization and low-temperature sterilization, in the healthcare industry.

Based on type, the endoscope reprocessing consumables segment holds the largest market share during the forecast period.
Based on type, the infection control market is segmented into endoscope reprocessing consumables, endoscope reprocessing equipment, and other endoscope reprocessing products.In 2020, the endoscope reprocessing consumables segment accounted for the largest share of the endoscope reprocessing products market.

Endoscope reprocessing consumables are used in large quantities and have a short shelf life. This, coupled with the growing number of endoscopic surgeries due to the increasing burden of chronic diseases, contributes to the large share of this market...

Based on end user, the hospitals segment is expected to register the highest CAGR during the forecast period.
Based on end user, the infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, life science industry, food industry, and other end users (cosmetic industry, dietary supplement manufacturers, the veterinary industry, and other healthcare providers such as long-term care facilities and diagnostic & imaging centers).The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period.

The overall demand for infection control in hospitals is largely driven by the increasing prevalence of HAIs, the increasing number of hospitals and clinics worldwide, and the rising geriatric population (as this population segment is more susceptible to various chronic diseases). The growing volume of surgical procedures performed is also expected to propel market growth.

North America is expected to account for the largest share of the infection control market in 2020
In 2020, North America accounted for the largest share of the infection control market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.The region’s large share can be attributed to the growing demand for and adoption of sterilization and disinfection products along with services as a result of the rising focus on healthy lifestyles and disease prevention among consumers.

The surge in the geriatric population in the coming years and the subsequent increase in the prevalence of chronic diseases, the need for infection control to minimize the prevalence of HAIs, and implementation of favorable government initiatives and stringent regulations on sterilization and disinfection are also propelling the infection control market in the region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Infection Control market
The key players operating in the infection control market include Getinge AB (Sweden), STERIS plc. (US), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), Cantel Medical Corporation (US), MMM Group (Germany), MATACHANA GROUP (Spain), Sotera Health LLC (US), Ecolab, Inc. (US), Metrex Research Corporation (US), Reckitt Benckiser Group Plc. (UK), Miele Group (Germany), Melag (Germany), and Pal International (UK).

Research Coverage:
The report analyzes the infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as product & services, end user, and region.The report also includes a product portfolio matrix of various infection control products and services available in the market.

The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection control market. The report analyzes this market by product & service and end user
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection control market
• Market Development: Comprehensive information on the lucrative emerging markets by product & service and end user
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection control market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection control market.
Read the full report: https://www.reportlinker.com/p04230312/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting